Lymphoma is a type of blood cancer that develops in the lymphatic system, an essential part of the immune system. This condition occurs when lymphocyte cells grow abnormally and uncontrollably, disrupting the body’s defense mechanism. Symptoms may vary, but the most common include enlarged lymph nodes, unexplained fever, excessive night sweats, drastic weight loss, fatigue, and itchy skin. Because these symptoms often resemble general illnesses, early detection by a specialist is crucial for faster and more effective treatment.
At Mandaya Royal Hospital Puri, patients can find a complete and experienced team of lymphoma specialists with advanced expertise in Hematology–Medical Oncology (KHOM). This team includes senior doctors such as Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP and Dr. Toman T.J Lumban Toruan, Sp.PD-KHOM, who are widely recognized for their expertise in managing lymphoma. With in-depth knowledge and modern medical facilities, Mandaya Royal Hospital Puri has become a trusted referral center for the diagnosis and treatment of lymphoma in West Jakarta and Tangerang.
Contents
Lymphoma Specialists in West Jakarta and Tangerang at Mandaya Royal Hospital Puri
Here are the lymphoma specialists practicing at Mandaya Royal Hospital Puri:
1. Dr. Toman T.J Lumban Toruan, Sp.PD-KHOM
Dr. Toman T.J Lumban Toruan, Sp.PD-KHOM is an internal medicine specialist with deep expertise in Hematology–Medical Oncology, including the treatment of lymphoma. He completed his medical degree at Universitas Indonesia and continued his subspecialty training in Hematology–Medical Oncology at Cipto Mangunkusumo Hospital. His international experience includes an Honorary Fellowship (Clinical Observership) at the Department of Hematology, National University Hospital, Singapore.
Dr. Toman has extensive experience in various lymphoma treatments, including chemotherapy, immunotherapy, targeted therapy, and apheresis.
Practice schedule at Mandaya Royal Hospital Puri:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. Dr. Alvin Tagor Harahap, Sp.PD-KHOM
Dr. Alvin Tagor Harahap, Sp.PD-KHOM is an internal medicine specialist with a subspecialty in Hematology–Medical Oncology, treating various types of lymphoma and hematologic disorders. He completed his general medical degree, internal medicine residency, and KHOM consultant training at Universitas Indonesia.
With comprehensive expertise in chemotherapy, immunotherapy, targeted therapy, and apheresis, Dr. Alvin is an important member of the lymphoma specialist team at Mandaya Royal Hospital Puri.
Practice schedule:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. DR. Aru W. Sudoyo is one of Indonesia’s leading experts in cancer and hematology, including lymphoma care. He completed his general medical education, internal medicine specialization, and Hematology–Medical Oncology consultant training at Universitas Indonesia, where he also earned his doctoral degree.
As a senior clinician and academic, Prof. Aru is proficient in multiple lymphoma treatment modalities, including chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy. He provides comprehensive care for patients at Mandaya Royal Hospital Puri.
Practice schedule:
- Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM is an internal medicine specialist experienced in managing lymphoma and various complex hematologic conditions. He is skilled in modern therapeutic approaches such as chemotherapy, immunotherapy, and targeted therapy.
With a personalized and patient-centered approach, Dr. Andree helps determine the most effective and safest lymphoma treatment strategy.
Practice schedule:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. Dr. Nia Noviantri Siregar, Sp.PD, Subsp.H-Onk.M (K)
Dr. Nia Noviantri Siregar, Sp.PD, Subsp.H-Onk.M (K) is a Hematology–Medical Oncology consultant experienced in treating lymphoma and various complex hematologic disorders. She is competent in chemotherapy, immunotherapy, targeted therapy, and comprehensive cancer care based on the latest medical advancements.
Dr. Nia is known for her meticulous and outcome-focused approach to patient care.
Practice schedule:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Lymphoma Treatments at Mandaya Royal Hospital Puri
1. Chemotherapy
Chemotherapy is a cancer treatment that uses powerful medications. Many types of chemotherapy drugs exist—most are administered intravenously, while some are available in tablet form.
Chemotherapy may be used for several types of lymphoma. You may receive a combination of chemotherapy drugs. It can also be combined with immunotherapy or other medications. Additionally, chemotherapy can be given for refractory lymphoma (when it does not respond to previous therapy) or relapsed lymphoma (when it returns after treatment).
2. Immunotherapy
Immunotherapy is a cancer treatment that helps the immune system attack cancer cells. The immune system combats diseases by targeting foreign or abnormal cells. Cancer cells can evade detection, but immunotherapy helps immune cells recognize and destroy them.
Immunotherapy may be an option for several types of lymphoma. It may be combined with chemotherapy or other medications and is also used for refractory and relapsed lymphoma.
3. Radiotherapy
Radiotherapy uses high-energy beams to kill cancer cells. These can come from X-rays, protons, or other sources.
During radiotherapy, you will lie on a special table while a machine moves around your body, directing precise beams of radiation to targeted areas.
Radiotherapy can be used to treat certain types of lymphoma. It may be combined with chemotherapy or other drugs. It can also help relieve symptoms and improve quality of life in specific lymphoma cases.
4. Targeted Therapy
Targeted therapy uses medications to attack specific molecules within cancer cells. By blocking these targets, the treatment can cause cancer cells to die.
Targeted therapy may be an option for several types of lymphoma, including refractory or relapsed B-cell lymphoma.
Mandaya Blood Cancer Center in Collaboration with Singapore
The Mandaya Blood Cancer Center has formed a strategic partnership with the National University Cancer Institute, Singapore (NCIS-NUH). Through this collaboration, every blood cancer case treated at Mandaya Royal Hospital Puri is jointly reviewed with experts from NCIS-NUH as part of a comprehensive medical evaluation.
This partnership offers significant benefits to patients, including more accurate and personalized medical recommendations—from confirming diagnoses to monitoring treatment effectiveness and determining the most suitable therapy. This collaborative approach ensures every patient receives optimal, precise, and internationally standardized care.
To make your visit to Mandaya Royal Hospital Puri easier and connect with our KHOM specialists, use the WhatsApp Chat feature, Book Appointment, or the Care Dokter app available on Google Play and the App Store to help with scheduling, queue numbers, and complete service information.
